The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Best Dividend ETFs highlights top options for generating income and potential appreciation. This intro guides you through evaluating yields and costs.
13,171 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Regulators in the UK are moving to dissolve a crypto exchange accused of aiding sanctions evasion. This article break...
For years, headlines have proclaimed Bitcoin dead. Yet the asset keeps proving skeptics wrong. This article breaks do...
Palantir often looks pricey at first glance, but the real story may be hidden in growth engines and future contracts....
Three weeks into iran, the conflict has pushed energy prices higher and tightened budgets for families. Here’s what h...
United Airlines outlines a high-oil-price scenario that could push fuel costs well above $20 billion this year. The p...
In March 2026, Anduril landed a long-term Army contract valued up to $20 billion, moving defense tech from pilots to ...
Volatility kept markets unsettled this week. Advisers say the right move depends on timelines and cash needs, with ma...
Japan sees renewed toilet paper stockpiling as global oil-market jitters ripple through households. Officials urge ca...
A public breakup can hit more than emotions; it can upend budgets and future plans. This guide uses the kelly osbourn...
Rivian vs. Lucid pits two high-profile EV startups against each other. This guide breaks down business models, capita...
EchoStar joined the S&P 500 on March 23, 2026, carrying unusually high short interest. This article examines the setu...